» Articles » PMID: 37440908

Identification, Structure Elucidation and Origin of a Common Pyridinium-thiocyanate Intermediate in Electrospray Mass Spectrometry Among the Benziamidazole-class Proton Pump Inhibitors

Overview
Journal J Pharm Anal
Specialty Chemistry
Date 2023 Jul 13
PMID 37440908
Authors
Affiliations
Soon will be listed here.
Abstract

During the analysis of benziamidazole-class irreversible proton pump inhibitors, an unusual mass spectral response with the mass-to-charge ratio at [M+10] intrigued us, as it couldn't be assigned to any literature known relevant structure, intermediate or adduct ion. Moreover, this mysterious mass pattern of [M+10] has been gradually observed by series of marketed proton pump inhibitors, viz. omeprazole, pantoprazole, lansoprazole and rabeprazole. All the previous attempts to isolate the corresponding component were unsuccessful. The investigation of present work addresses this kind of signal to a pyridinium thiocyanate mass spectral intermediate , which is the common fragment ion of series of labile aggregates. The origin of such aggregates can be traced to the reactive intermediates formed by acid-promoted degradation. These reactive intermediates tend to react with each other and give raise series of complicated aggregates systematically in a water/acetonitrile solution by electrospray ionization. The structure of the corresponding pyridinium thiocyanate species of omeprazole () has been eventually characterized with the help of synthetic specimen (). Our structural proposal as well as its origin was supported by in situ nuclear magnetic resonance, chemical derivatization and colorimetric experiments.

Citing Articles

Real-time platelet P2Y receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK/PD of clopidogrel therapy.

Li H, Gu Y, Zhao Y, Xu A, Sun D, Gu J Acta Pharm Sin B. 2025; 15(1):484-493.

PMID: 40041905 PMC: 11873646. DOI: 10.1016/j.apsb.2024.08.008.


Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article.

Wagih N, Abdel-Rahman I, El-Koussi N, Abuo-Rahma G RSC Adv. 2025; 15(2):966-1010.

PMID: 39807197 PMC: 11726184. DOI: 10.1039/d4ra05014b.

References
1.
Shin J, Cho Y, Sachs G . Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc. 2004; 126(25):7800-11. DOI: 10.1021/ja049607w. View

2.
Shin J, Munson K, Vagin O, Sachs G . The gastric HK-ATPase: structure, function, and inhibition. Pflugers Arch. 2008; 457(3):609-22. PMC: 3079481. DOI: 10.1007/s00424-008-0495-4. View

3.
Bogseth R, Edgcomb E, Jones C, Chess E, Hu P . Acetonitrile adduct formation as a sensitive means for simple alcohol detection by LC-MS. J Am Soc Mass Spectrom. 2014; 25(11):1987-90. DOI: 10.1007/s13361-014-0975-z. View

4.
Gupta V, Carroll K . Profiling the Reactivity of Cyclic C-Nucleophiles towards Electrophilic Sulfur in Cysteine Sulfenic Acid. Chem Sci. 2016; 7(1):400-415. PMC: 4724439. DOI: 10.1039/C5SC02569A. View

5.
Ward R, Kearns G . Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs. 2013; 15(2):119-31. PMC: 3616221. DOI: 10.1007/s40272-013-0012-x. View